Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CJ-12420 Triple Therapy for H. pylori
NCT03317223Phase 3Completed
- Sponsor
- HK inno.N Corporation
- Start
- Oct 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegoprazan in Helicobacter pylori infection, sponsored by HK inno.N Corporation. Started Oct 2017; status: completed.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03317223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03317223.